Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial
PaperCitations, authors & open-access status
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 271 citations, 2019 year and closed oa status.
271
Citations
2019
Year
closed
OA Status